Recent Updates
Recently added Catalysts
BIIB

“LEQEMBI®” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in China

Key Takeaway: “LEQEMBI®” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in China

Full Press Release Details

“LEQEMBI®” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in China.
Last updated: Jan 9, 2024